| Revenues | | 30.84 | 32.43 | 32.86 | 31.52 |
| Cost Of Revenue | | 7.48 | 7.99 | 8.40 | 8.22 |
| Gross Profit | | 23.37 | 24.45 | 24.46 | 23.31 |
| | 28.43 | 28.95 | 29.37 | 27.93 |
| Research and Development | | 9.41 | 9.47 | 8.52 | 7.33 |
| Operating Income/Loss | | -5.06 | -4.51 | -4.91 | -4.62 |
| Income/Loss From Equity Method Investments | | -0.38 | - | - | - |
| Income/Loss From Continuing Operations Before Tax | | -5.02 | -3.13 | 12.44 | -3.61 |
| Income Tax Expense/Benefit | | 0.06 | 0.15 | 0.03 | 0.04 |
| Income/Loss From Continuing Operations After Tax | | -5.47 | -3.28 | 12.41 | -3.65 |
| Income/Loss From Discontinued Operations, Net Of Tax | | -2.58 | -0.18 | 0.12 | -3.00 |
| | -8.05 | -3.46 | 12.53 | -6.65 |
| Attributable To Parent | | -8.05 | -3.46 | 12.53 | -6.65 |
| Available To Common Stockholders, Basic | | -12.78 | -8.15 | 7.97 | -11.02 |
| Basic Average Shares | | 255.63 | - | 259.63 | 259.21 |
| Diluted Average Shares | | 255.63 | - | 268.72 | 259.21 |
| Basic Earnings Per Share | | -0.05 | - | 0.03 | - |
| Diluted Earnings Per Share | | -0.05 | - | 0.02 | - |
BLND
